The Next Bottleneck: Where AI Creates Value in Biotech

AI is making drug discovery look increasingly like software: faster, cheaper, and more powerful with every generation of models.
But the rest of drug development has not moved at the same speed.
AI can now design and identify promising drug candidates faster than ever, while the path through clinical development remains narrow, expensive, and uncertain. If discovery becomes dramatically easier, the bigger question is where the bottleneck moves next, and where the value moves with it.
As part of DeepTech Week, Grove Ventures and ARC Innovation at Sheba Medical Center are bringing together…

Hosted by Vicky Books / Grove & 4 others